| Name | Title | Contact Details |
|---|
Sterling Bank "Your one-customer bank" is a full service national commercial bank in Nigeria which has evolved from the nations pre-eminent investment banking institution to a fully-fledged commercial bank. Sterling Bank prides itself in its purpose to ‘Enrich Lives, and reflects its overall business aspirations in its vision to ‘be the financial institution of choice. This it plans to achieve by (mission) ‘delivering solutions that enhance stakeholders value, through four core values: Customer focus, Integrity, Teamwork and Excellence (CITE). With strong Corporate Governance, the bank has a vision-led and values-driven experienced team with a track record of delivery. With over 3,000 professional employees, Sterling Bank has about 1,000,000 active customers, and operates from 189 business offices, about 776 ATMs and more than 3,000 POS terminals across Nigeria. Sterling Bank operates with a three-pronged market focus. Its business lines and operations are structured around these segments; Retail and Consumer market, Commercial and Institutional market and Corporate and Investment market. Our purpose of enriching lives is what drives us to support society. We have contributed positively to our environment through several initiatives such as #STEM (Sterling Environmental Makeover), Meet The Executives, Get Ready For Work, Sketchamania, and several other interventions within other areas especially Education.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
LFI specializes in the sale and service of contemporary furnishings to public, private, school, and academic libraries. By meeting the rapidly changing sociological and technological changes through design and product, LFI has become the Midwests leading library furnishing company.
Think Company is an award-winning experience design and development consultancy. Our team understands highly-regulated and complex markets, shapes solutions using data, and has a proven track record for building world-class digital experiences at scale. Come think with us!